Envision Pharma Group’s Post

If you missed last week’s webinar showcasing technology’s transformative potential in medical affairs, check out the insights and recording below for a concrete vision of AI’s future. The webinar is a perfect place to start for those just starting their AI journey or looking for a refresher. My favorite insight was that early adopters will be the real winners, and the time to act is now, so don’t get caught flat-footed.  

It is never too late to learn about new technologies. After all, those who don't adapt perish. That's why I am excited to join the webinar about AI inclusion in the Medical field. #ai #medicalaffairs #sorcero #webinar

Access the full potential of your medical data with Sorcero's Instant Insights Engine™! This transformative AI-powered tool is revolutionizing how Medical Affairs teams harness complex information. With advanced, medically-tuned algorithms, the Instant Insights Engine: ✅ Translates intricate medical terminology into plain language ✅ Surfaces new patterns and insights by connecting the dots across a vast range of data sources ✅ Grounds responses in real evidence to support collaborative decision-making As our latest Winter 2024 release, the Instant Insights Engine provides a simple conversational interface for asking and answering complex medical questions. It draws upon internal and external data - from CRMs to claims databases - to generate high-quality, medically intelligent answers. See the Instant Insights Engine in action and learn how it can empower your Medical Affairs team: https://hubs.li/Q02shYZg0 Schedule a demo to experience this game-changing technology firsthand. Reach out to our team today: https://hubs.li/Q02sj0BW0 #MedicalAffairs #DataInsights #AI #HealthcareTech

Google Unveils AMIE: An AI for Doctor-Patient Dialogue and Diagnostics Big news in the healthcare world! Google Research has introduced AMIE (Articulate Medical Intelligence Explorer), a research AI system designed to support medical professionals through diagnostic conversations. Here's what AMIE can do: Engage in Diagnostic Dialogues: AMIE can converse with doctors, asking relevant questions and analyzing patient medical history to explore potential diagnoses. Improve Diagnostic Accuracy: By considering various factors, AMIE aims to assist doctors in reaching more accurate diagnoses. Enhance Patient Care: Effective communication is crucial in medicine. AMIE's conversational abilities could potentially streamline communication between doctors and patients. Challenges and Development: Mimicking Medical Expertise: Matching the knowledge and experience of doctors is a significant hurdle. Data Training: AMIE is trained on real-world datasets like medical questionnaires and doctor-patient interactions. However, ensuring data comprehensiveness and addressing potential biases are ongoing efforts. Overall, AMIE represents a significant step forward in AI-powered medical diagnostics. While still under development, it has the potential to revolutionize doctor-patient communication and improve healthcare delivery

⚡️🚀 We often think about Medical Affairs as a necessary function in Biopharma, but have we truly considered its potential as an instrumental and independently functioning business unit, dedicated solely to amplifying patient outcomes? 🎯 Could our leadership tactics shift if we start viewing Medical Affairs not just as a function, but a stand-alone unit with a mission devoted entirely to enhancing patient impact? As Biopharma pioneers, we have a tremendous mandate to foster that change, to elevate the leaders in Medical Affairs, and drive patient-centric impact. How do we facilitate this vision? Enter Generative AI. Such as GPT-4, the latest AI model from OpenAI, which could become every Biopharma leader's right hand. What Generative AI can provide: 🔹Personalized patient experiences: Imagine providing custom-tailored, precision-based care plans and communication to patients 🔹Acceleration of drug discovery: According to recent studies, AI can accelerate drug discovery timelines by an unprecedented margin 🔹Knowledge platform: AI models equipped with the latest in medical knowledge could support the physician community with the newest breakthroughs in real-time To translate vision into action, here’s a proposal: 🔘Embed AI in the Medical Affairs Business Unit - Drive patient level impact with advanced AI tools 🔘Empower Medical Affairs Leaders - Ongoing training and support for leaders in utilising AI for decision making 🔘Invest in AI-centric Innovation - Devote a portion of the budget towards the innovation and integration of AI in the medical affairs unit Recognizing the potential of Medical Affairs as a stand-alone business unit, rather than a subsidiary function, will facilitate a transformation in both organization and patient impact. Seize the potential, embrace the vision, and unlock next-level progress in Biopharma. Together, let's strive for a future where pharma and AI synergize, ensuring the best patient outcomes.💡🔬 #biopharma #medicalaffairs #generativeai

🚀 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗮𝗻𝗱 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲! 🚀 What do we know about AI in clinical trials so far? Not much because we just started integrating the two, only a labyrinth of opportunities yet to be explored, lying ahead of us. But for now let’s start with ; 📈𝗧𝗵𝗲 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀: 𝗧𝗿𝗮𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗮𝗿𝗲 𝗽𝗹𝗮𝗴𝘂𝗲𝗱 𝗯𝘆: ⏳ 𝗛𝗶𝗴𝗵 𝗧𝗶𝗺𝗲 𝗮𝗻𝗱 𝗖𝗼𝘀𝘁: It takes 10-15 years and $2 billion on average to bring a new drug to market. 👥 𝗥𝗲𝗰𝗿𝘂𝗶𝘁𝗺𝗲𝗻𝘁 𝗗𝗶𝗳𝗳𝗶𝗰𝘂𝗹𝘁𝗶𝗲𝘀: Only 5% of eligible patients participate due to stringent criteria and geographical constraints. 📂 𝗗𝗮𝘁𝗮 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗜𝘀𝘀𝘂𝗲𝘀: Manual data handling consumes 80% of researchers' time. 𝗧𝗮𝗯𝗹𝗲: The High Costs of Traditional Clinical Trials | 𝗦𝘁𝗮𝗴𝗲 𝗼𝗳 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁            | 𝗔𝘃𝗲𝗿𝗮𝗴𝗲 𝗖𝗼𝘀𝘁   | | Pre-clinical Development         | $0.2-$0.5 billion | | Phase I Clinical Trials            | $0.1-$0.2 billion | | Phase II Clinical Trials            | $0.5-$1 billion   | | Phase III Clinical Trials           | $1-$2 billion    | | Regulatory Approval Process      | $0.1-$0.2 billion | 🤖𝗧𝗵𝗲 𝗔𝗜 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻: 𝗔𝗜 𝗶𝘀 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗯𝘆: ⚡𝗕𝗼𝗼𝘀𝘁𝗶𝗻𝗴 𝗘𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆: AI automation can save up to 80% in costs, as per a 2021 Accenture study. 📈 𝗘𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗴 𝗥𝗲𝗰𝗿𝘂𝗶𝘁𝗺𝗲𝗻𝘁: AI strategies can increase enrollment rates by 50%, reducing bias (JMIR Medical Informatics, 2019). 🌐 𝗨𝘁𝗶𝗹𝗶𝘇𝗶𝗻𝗴 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲: AI integrates data from EHRs and wearables, providing comprehensive insights (Nature Reviews Drug Discovery, 2020). 🔍 𝗜𝗺𝗽𝗿𝗼𝘃𝗶𝗻𝗴 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝗔𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀: Real-time data analysis helps identify safety concerns and predict outcomes, increasing trial success rates by 10-15% (McKinsey). 🌟𝗙𝘂𝘁𝘂𝗿𝗲 𝗣𝗿𝗼𝘀𝗽𝗲𝗰𝘁𝘀: AI promises a new era in clinical research, offering personalized, efficient, and effective medical care by overcoming traditional limitations. 𝗦𝘁𝗮𝘆 𝘁𝘂𝗻𝗲𝗱 𝗳𝗼𝗿 𝗼𝘂𝗿 𝗳𝘂𝗹𝗹 𝗲𝗯𝗼𝗼𝗸, 𝗰𝗼𝗺𝗶𝗻𝗴 𝗼𝘂𝘁 𝘀𝗼𝗼𝗻! You shall be intrigued... #AI #ClinicalTrials #Technology #Vaidhyamegha #ai #EBook

Embracing the Future of Medical Affairs!The Power of AI After two decades working in pharmaceutical business and healthcare I am not only witnessing but actively driving the transformative impact of Artificial Intelligence in our field. The integration of AI holds the promise of revolutionizing healthcare, and I'm committed to leveraging this potential to deliver unparalleled value to patients and stakeholders. When envisioning AI's role in medicine, my focus naturally gravitates towards our core capabilities: data generation and analytics, scientific communications, healthcare stakeholder engagement, and fostering partnerships to ensure equal access to innovation. AI-powered analytics have empowered me to navigate through vast datasets, extracting crucial insights and uncovering patterns that were once elusive. This not only accelerates decision-making but also elevates the precision of our strategies. Collaboration lies at the heart of my professional ethos. Through AI-driven platforms, I've connected with experts across borders, fostering knowledge exchange and propelling innovation at an unprecedented pace. Together, we're forging a path towards a more accessible, personalized, and effective future of healthcare. While AI amplifies our capabilities, it never replaces the irreplaceable human touch. By automating routine tasks, we liberate valuable time for high-level strategic thinking, creativity, and empathy – the cornerstones of exceptional patient-centric care. The road ahead is laden with opportunities to harness AI in Medical Affairs, from optimizing clinical trial design to harnessing real-world evidence generation. I'm eager to hear your thoughts on how AI is shaping the future of Medical Affairs. What breakthroughs or trends are you most excited about? #MedicalAffairs #AIinHealthcare #FutureofHealthcare #InnovationInMedicine #LeadershipInHealthcare

[ Fresh Blog Post ] Staying on top of the latest medical research and insights is crucial, but often challenging, for medical affairs teams. A new post on the Sorcero blog explores how AI is helping collapse the distance between medical affairs professionals and the information they need to drive progress. The article examines how natural language processing enables AI systems to rapidly synthesize findings across massive volumes of medical literature. This allows medical affairs teams to efficiently identify crucial new evidence and insights relevant to their therapeutic area. By leveraging AI, medical affairs leaders can promote more informed clinical trial design, optimize data analysis, and ensure messaging is strongly backed by current research. This ultimately helps bring novel treatments to patients faster. At Sorcero, we're using advanced AI to transform how medical insights are discovered and applied. Learn more in our latest blog post: https://hubs.li/Q028Qg150 #medaffairs #biopharma #pharma #healthtech #digitalhealth

Generative AI's Impact on Medical Affairs Roles and Responsibilities: Evidence Generation: ✅ Generative AI accelerates the process of analyzing vast amounts of data to generate robust evidence and actionable insights. ✅ Rapid identification of key findings and trends from diverse sources including medical literature, clinical trial data, and real-world evidence. ✅ Empowers Medical Affairs to contribute to informed decision-making and scientific advancements. Content Dissemination: ✅ Personalized, targeted content creation for HCPs and payers. ✅ Tailors educational materials, scientific publications, and evidence-based communications to meet specific audience needs. ✅ Enhances the effectiveness of communication efforts, ensuring the right information reaches the right audience in a compelling and impactful manner. 🚀 Relationship Management with Key Opinion Leaders and Stakeholders: ✅ Identification, analysis, and management of relationships with key opinion leaders and stakeholders. ✅ Provides insights into KOL sentiments, interests, and influence to craft more strategic engagement strategies. ✅ Fosters stronger relationships and enhances collaboration in scientific endeavors. 💬 Compliance and Regulatory Support: ✅ Automates the creation of scientifically accurate and compliant content. ✅ Supports the maintenance of ethical and legal standards in evidence communication. ✅ Assists in identifying and addressing potential risks associated with regulatory requirements. 📝 Overall, Generative AI transforms Medical Affairs by enhancing the division's ability to deliver impactful insights and drive positive outcomes in the biopharma industry. #generativeai #biopharma #medicalaffairs